Literature DB >> 3137629

Physostigmine accelerates the development of associative memory processes in the infant rat.

T B Moye1, J Vanderryn.   

Abstract

Previous research has shown that 15-day-old rats are quite poor at associating temporally separated events. However, by 17 days of age, this capability has improved substantially (Moye and Rudy 1987a). In the present study, the centrally active anticholinesterase physostigmine was found to enhance the ability of 15-day-olds to associate a tone conditioned stimulus (CS) with a shock unconditioned stimulus (US) when these events were separated by a 10-s trace interval. In effect, the drug produced trace conditioning performance similar to that observed in older animals. We suggest that performance in the trace conditioning task requires the development of associative memory processes that allow the young rat to retain a representation of a CS over time. Furthermore, the enhancement of trace conditioning by physostigmine indicates that central cholinergic maturation is an important factor in the expression of associative memory.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137629     DOI: 10.1007/bf00181956

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Human memory and the cholinergic system. A relationship to aging?

Authors:  D A Drachman; J Leavitt
Journal:  Arch Neurol       Date:  1974-02

2.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

Review 4.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

5.  Age-related disruption of trace but not delay classical conditioning of the rabbit's nictitating membrane response.

Authors:  C A Graves; P R Solomon
Journal:  Behav Neurosci       Date:  1985-02       Impact factor: 1.912

6.  Ontogenesis of learning: VI. Learned and unlearned responses to visual stimulation in the infant hooded rat.

Authors:  T B Moye; J W Rudy
Journal:  Dev Psychobiol       Date:  1985-09       Impact factor: 3.038

7.  Hippocampus and trace conditioning of the rabbit's classically conditioned nictitating membrane response.

Authors:  P R Solomon; E R Vander Schaaf; R F Thompson; D J Weisz
Journal:  Behav Neurosci       Date:  1986-10       Impact factor: 1.912

8.  Retention and acquisition of classical trace conditioned responses by rabbits with hippocampal lesions.

Authors:  R L Port; A G Romano; J E Steinmetz; A A Mikhail; M M Patterson
Journal:  Behav Neurosci       Date:  1986-10       Impact factor: 1.912

9.  Basal forebrain infusion of HC-3 in rats: maze learning deficits and neuropathology.

Authors:  B J Hurlbut; J F Lubar; R Switzer; J Dougherty; M L Eisenstadt
Journal:  Physiol Behav       Date:  1987

10.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

View more
  4 in total

1.  Effect of oxotremorine, physostigmine, and scopolamine on brain acetylcholine synthesis: a study using HPLC.

Authors:  N Bertrand; A Beley
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

2.  Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock.

Authors:  J Itoh; T Nabeshima; T Kameyama
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects.

Authors:  D A Cory-Slechta; K M Crofton; J A Foran; J F Ross; L P Sheets; B Weiss; B Mileson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

4.  The effects of piracetam on morphine-induced amnesia and analgesia: the possible contribution of central opiatergic mechanisms on the antiamnestic effect of piracetam.

Authors:  F Aksu; I Gültekin; S Y Inan; F Baysal
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 5.093

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.